A gain-of-function variation in PLCG1 causes a new immune dysregulation disease

Background: Phospholipase C (PLC) y1 is a critical enzyme regulating nuclear factor-kB (NF-kB), extracellular signal -related kinase, mitogen-activated protein kinase, and nuclear factor of activated T cells signaling pathways, yet germline PLCG1 mutation in human disease has not been reported. Objective: We aimed to investigate the molecular pathogenesis of a PLCG1 activating variant in a patient with immune dysregulation. Methods: Whole exome sequencing was used to identify the patient's pathogenic variants. Bulk RNA sequencing, single-cell RNA sequencing, quantitative PCR, cytometry by time of flight, immunoblotting, flow cytometry, luciferase assay, IP-One ELISA, calcium flux assay, and cytokine measurements in patient PBMCs and T cells and COS-7 and Jurkat cell lines were used to define inflammatory signatures and assess the impact of the PLCG1 variant on protein function and immune signaling. Results: We identified a novel and de novo heterozygous PLCG1 variant, p.S1021F, in a patient presenting with early-onset immune dysregulation disease. We demonstrated that the S1021F variant is a gain-of-function variant, leading to increased inositol-1,4,5-trisphosphate production, intracellular Ca21 release, and increased phosphorylation of extracellular signal-related kinase, p65, and p38. The transcriptome and protein expression at the single-cell level revealed exacerbated inflammatory responses in the patient's T cells and monocytes. The PLCG1 activating variant resulted in enhanced NF-kB and type II interferon pathways in T cells, and hyperactivated NF-kB and type I interferon pathways in monocytes. Treatment with either PLCy1 inhibitor or Janus kinase inhibitor reversed the upregulated gene expression profile in vitro. Conclusions: Our study highlights the critical role of PLCy1 in maintaining immune homeostasis. We illustrate immune dysregulation as a consequence of PLCy1 activation and provide insight into therapeutic targeting of PLCy1.

Automated summary

This study highlights the critical role of PLCy1 in maintaining immune homeostasis and illustrates immune dysregulation as a consequence of PLCy1 activation. Additionally, we provide insight into therapeutic targeting of PLCy1.